Reimagining the future of healthcare

CHARLES / Huntington’s Disease Community Advocate

Home hero advocate charles

Press Releases

Sep 5, 2023
uniQure Announces FDA Clearance of Investigational New Drug Application for AMT-260 Gene Therapy for Refractory Mesial Temporal Lobe Epilepsy
Aug 1, 2023
uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress
Jun 26, 2023
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs

See All

Follow Us @uniQure_NV

32Could not authenticate you.